78 related articles for article (PubMed ID: 18534061)
1. Serum leptin level in acute myeloid leukemia patients.
Yilmaz M; Kis C; Ceylan NO; Okan V; Pehlivan M; Kuçukosmanoglu E; Yilmaz F; Tarakcioglu M
Hematology; 2008 Feb; 13(1):21-3. PubMed ID: 18534061
[TBL] [Abstract][Full Text] [Related]
2. Impact of serum adiponectin and leptin levels in acute leukemia.
Aref S; Ibrahim L; Azmy E; Al Ashary R
Hematology; 2013 Jul; 18(4):198-203. PubMed ID: 23321463
[TBL] [Abstract][Full Text] [Related]
3. Leptin in acute leukaemias: relationship to interleukin-6 and vascular endothelial growth factor.
Hamed NA; Sharaki OA; Zeidan MM
Egypt J Immunol; 2003; 10(1):57-66. PubMed ID: 15719623
[TBL] [Abstract][Full Text] [Related]
4. Leptin in human acute myelogenous leukemia: studies of in vivo levels and in vitro effects on native functional leukemia blasts.
Bruserud Ø; Huang TS; Glenjen N; Gjertsen BT; Foss B
Haematologica; 2002 Jun; 87(6):584-95. PubMed ID: 12031914
[TBL] [Abstract][Full Text] [Related]
5. Disease-stabilizing treatment with all-trans retinoic acid and valproic acid in acute myeloid leukemia: serum hsp70 and hsp90 levels and serum cytokine profiles are determined by the disease, patient age, and anti-leukemic treatment.
Fredly H; Reikvam H; Gjertsen BT; Bruserud O
Am J Hematol; 2012 Apr; 87(4):368-76. PubMed ID: 22374841
[TBL] [Abstract][Full Text] [Related]
6. Serum erythropoietin levels in patients with leukemia on cytostatic treatment.
Aydogdu I; Ilhan O; Beksac M; Koc H; Akan H; Konuk N; Uysal A
Haematologia (Budap); 1998; 29(2):133-7. PubMed ID: 9728805
[TBL] [Abstract][Full Text] [Related]
7. [A histopathological study of bone marrow following chemotherapy of acute myeloid leukemia].
Pu Q
Zhonghua Yi Xue Za Zhi; 1991 Aug; 71(8):431-3, 30. PubMed ID: 1660761
[TBL] [Abstract][Full Text] [Related]
8. Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome.
Dalamaga M; Karmaniolas K; Chamberland J; Nikolaidou A; Lekka A; Dionyssiou-Asteriou A; Mantzoros CS
Metabolism; 2013 Dec; 62(12):1830-9. PubMed ID: 24140093
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum endostatin levels are associated with favorable outcome in acute myeloid leukemia.
Aref S; El-Sherbiny M; Azmy E; Goda T; Selim T; El-Refaie M; Twafik E
Hematology; 2008 Apr; 13(2):95-100. PubMed ID: 18616876
[TBL] [Abstract][Full Text] [Related]
10. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors.
Carlo-Stella C; Tabilio A; Regazzi E; Garau D; La Tagliata R; Trasarti S; Andrizzi C; Vignetti M; Meloni G
Bone Marrow Transplant; 1997 Sep; 20(6):465-71. PubMed ID: 9313879
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment prognostic factors for overall survival in primary resistant acute myeloid leukemia.
Colovic N; Tomin D; Vidovic A; Suvajdzic N; Jankovic G; Palibrk V; Djunic I; Djurasinovic V; Virijevic M
Biomed Pharmacother; 2012 Dec; 66(8):578-82. PubMed ID: 23085253
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological purging of minimal residual disease from peripheral blood stem cell collections of acute myeloblastic leukemia patients: preclinical studies.
Motta MR; Mangianti S; Rizzi S; Ratta M; Campanini E; Fortuna A; Fogli M; Tura S; Lemoli RM
Exp Hematol; 1997 Nov; 25(12):1261-9. PubMed ID: 9357970
[TBL] [Abstract][Full Text] [Related]
13. [Leptin and its receptor in acute myeloid leukemia].
Ning HM; Zhang Y; Mao N
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):234-7. PubMed ID: 20137154
[TBL] [Abstract][Full Text] [Related]
14. The imbalanced profile and clinical significance of T helper associated cytokines in bone marrow microenvironment of the patients with acute myeloid leukemia.
Sun YX; Kong HL; Liu CF; Yu S; Tian T; Ma DX; Ji CY
Hum Immunol; 2014 Feb; 75(2):113-8. PubMed ID: 24269703
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of endothelium-derived endocan are increased in patients with untreated acute myeloid leukemia.
Hatfield KJ; Lassalle P; Leiva RA; Lindås R; Wendelboe Ø; Bruserud Ø
Hematology; 2011 Nov; 16(6):351-6. PubMed ID: 22183069
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cells in bone marrow at diagnosis and after chemotherapy in adult patients with acute myeloid leukaemia.
Derolf AR; Laane E; Björklund E; Saft L; Björkholm M; Porwit A
Scand J Immunol; 2014 Dec; 80(6):424-31. PubMed ID: 25346147
[TBL] [Abstract][Full Text] [Related]
17. The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement.
Castagnola C; Nozza A; Corso A; Bernasconi C
Haematologica; 1997; 82(5):577-80. PubMed ID: 9407724
[TBL] [Abstract][Full Text] [Related]
18. [Ferritin in acute leukemia. Serum ferritin concentration as a nonspecific tumor marker for M1 and M2 myeloid leukemia].
Aulbert E; Fromm H; Hornemann H
Med Klin (Munich); 1991 Jun; 86(6):297-304. PubMed ID: 1886510
[TBL] [Abstract][Full Text] [Related]
19. Classification of acute non-lymphocytic leukemia according to the distribution picture of peroxidase activity and cell size: correlation between the classification and therapeutic response.
Takubo T; Kubota Y; Oguma S; Ueda T; Shibata H; Nakamura H; Masaoka T; Yoshitake J; Ishigami S
Blood Cells; 1983; 9(3):501-14. PubMed ID: 6586210
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of the novel member of the BCL2 gene family, BCL2L12, is associated with the disease outcome in patients with acute myeloid leukemia.
Thomadaki H; Floros KV; Pavlovic S; Tosic N; Gourgiotis D; Colovic M; Scorilas A
Clin Biochem; 2012 Nov; 45(16-17):1362-7. PubMed ID: 22728012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
